Alex J.

CraniUS mission is to invent and engineer world-class technology to define the future of diagnostics and treatments for neurosurgical patients with brain disease. CAUTION – The NeuroPASS device is an investigational device limited by Federal (or United States) law to investigational use and is not available for commercial distribution.

Sterilex is a recognized leader in developing antimicrobial, anti-biofilm, and decontamination products for infection control, biofilm removal, bio-decontamination, and chemical decontamination. Sterilex specialty biofilm-control biocides, disinfectants, and decontamination products are used in a variety of applications including animal health, food processing, water care, industrial processing, and environmental remediation. Sterilex patented platform technology is based upon PerQuat® technology, an alkaline peroxygen phase-transfer chemistry which has the unique ability to penetrate and remove biofilms, kill microorganisms in biofilms, and remove organic contaminants. This chemistry is also effective in decontaminating chemical contaminants including nerve agents, organophosphorus pesticides, and carbamates.

Switz Advisory and Switz Capital Led by Alex Josowitz, a highly accomplished CEO, board member, consultant, and investor with a successful track record of building companies > 50X from startup to market leadership. Switz Advisory provides strategic consulting services to growth companies, institutional investors, and founders looking to rapidly scale businesses, professionalize operations, or develop a comprehensive business exit strategy. Switz Capital is the Angel Investment arm of Switz Venture Group providing funding for startup and high-growth potential businesses looking for a highly-engaged, strategic investment group who has "been there" to collaboratively guide businesses to rapid growth and successful outcomes. For more information, please contact alex.josowitz@switzventuregroup.com.

CraniUS mission is to invent and engineer world-class technology to define the future of diagnostics and treatments for neurosurgical patients with brain disease. CAUTION – The NeuroPASS device is an investigational device limited by Federal (or United States) law to investigational use and is not available for commercial distribution.